James L. Sherley, M.D., Ph.D.

Director , Asymmetrex, LLC

About James L. Sherley, M.D., Ph.D.

Asymmetrex is a for-profit biotechnology start-up company with a focus on development of tools that address the two essential barriers to biomedical development of adult tissue stem cells - tissue stem identification and tissue stem cell production. The company's lead applications are first-of-their kind technologies for identifying and counting adult tissue stem cells. These technologies inclu...

Asymmetrex is a for-profit biotechnology start-up company with a focus on development of tools that address the two essential barriers to biomedical development of adult tissue stem cells - tissue stem identification and tissue stem cell production. The company's lead applications are first-of-their kind technologies for identifying and counting adult tissue stem cells. These technologies include a portfolio of newly discovered mRNA and protein biomarkers with highly specific expression in asymmetrically self-renewing tissue stem cells. The the new biomarkers are patented for use to identify and quantify tissue stem cells. A second technology employs computer simulation to accurately estimate stem cell number in any primary or stem cell-enriched tissue cell culture. The computer simulation technology has applications for determining stem cell dose in transplantation treatment samples and for detection of stem cell-active agents, including drug candidates that will fail in animal studies and clinical trials because of intolerable tissue stem cell toxicity. Asymmetrex is also working with strategic partners to develop its patented technologies for expanding adult tissue stem cells for applications in drug discovery and stem cell transplantation medicine.

Contact James L. Sherley, M.D., Ph.D.

Web
http://asymmetrex.com
Phone Number
617-990-6819

Francisco dos Santos

Founder and CSO at Cell2B, Cell2B Advanced Therapeutics SA

Ryan Chang

President of Steminent Biotherapeutics, Steminent Biotherapeutics

Anthony Metcalfe

Professor of Burns and Wound Healing, University of Brighton & Blond McIndoe Research Foundation

Corey Orava, DVM

Veterinary Services Manager at Vet-Stem, Vet-Stem

Joe Riggs

Founder and Executive Director at Student Society for Stem Cell Research, Student Society for Stem Cell Research

Evan Snyder

Professor; Director, Center for Stem Cells & Regenerative Medicine; Director, Center for Stem Cell Research & Core Facility, Sanford-Burnham Medical Research Institute; Sanford Consortium for Regenerative Medicine; University of California-San Diego

Gail Naughton

CEO, Histogen Inc

Simon Bubnic

Development Scientist, Centre for Commercialization of Regenerative Medicine

Ken Igawa

M.D. and Ph.D., Department of Dermatology, Tokyo Medical and Dental University

Karina Benish

Manager of Clinical Development, Vet-Stem Regenerative Veterianry Medicine

Richard Grant

Product Design Consultant, FloDesign Sonics

Janet Macpherson

Director, SpanCyte Pty Ltd

Charles H Newcomer

CEO, World Stem Cells, LLC

Kathleen Heath

Cord Blood QA Manager, BioBridge Global; GenCure

andrea gutova

Ms, PrimeCell Therapeutics

Richard McMurtrey

Director, Institute of Neural Regeneration & Tissue Engineering

Alexander Seifalian

Professor of Nanotechnology & Regenerative Medicine at University College London, University College London

Michael Yuan

Director of Department, Cell Research Center

Nathalie Dusserre

VP Manufacturing & Regulatory Affairs at Cytograft Tissue Engineering, Inc., Cytograft Tissue Engineering, Inc.

Andy Kemp

Business Development Manager, Future Science Group

Heather Brown

Vice President, Scientific & Medical Affairs at Cord Blood Registry, Cord Blood Registry

New York Stem Cell Foundation

(NYSCF), Non-profit organization

Rajat Gupta

Healthcare & Regenerative Medicine Marketing Specialist, EmProcell Mumbai, INDIA.

Shweta Pardeshi

Clinical Coordinator, Emprocell Clinical Research Pvt Ltd

Aisha Abid

Medical Cordinator, Emprocell Clinical Research Pvt. Ltd`